Disease-focused collections, aligned to your protocol.

Disease-focused collections, aligned to your protocol.

Clinfound has experience supporting oncology biospecimen procurement across solid tumours and haematological malignancies. We assess each project against its scientific and operational requirements, including diagnosis, histology, stage, treatment status, tumour content and associated clinical data.

Indications previously supported in feasibility and procurement discussions include breast cancer, colorectal cancer, NSCLC, SCLC, PDAC, biliary tract cancer, TNBC, ovarian cancer, HNSCC, DLBCL and AML. Other indications may be considered following review.

For non-oncology programmes, we can assess requests involving neurological, inflammatory, dermatological and infectious disease cohorts, subject to site access and protocol feasibility.